Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,662 public trials 323 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice

NCT04659798

Conditions
Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +17 more
Locations
  • H. Puerta del Mar Cadiz, Andalusia, Spain
  • Hospital Regional Universitario de Malaga (Carlos de Haya) Málaga, Andalusia, Spain
  • H. Universitari Son Espases Palma de Mallorca, Balearic Islands, Spain
  • H. Universitario de Araba Vitoria-Gasteiz, Basque Country, Spain
View all 14 locations
View Trial Details
Completed

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

NCT03439293

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Pacific Cancer Medical Center Anaheim, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • SCRI - Florida Cancer Specialists - Panhandle Tallahassee, Florida, United States
  • Research Medical Center - Kansas City Kansas City, Missouri, United States
View all 28 locations
View Trial Details
Completed

Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

NCT03424603

Conditions
B Cells--Tumors, B-cell Lymphoma, Blood Protein Disorders, +26 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Oncology Associates, PC--HOPE Division Tucson, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
View all 22 locations
View Trial Details
Completed

A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Participants With Relapsed or Refractory Multiple Myeloma

NCT03234972

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Peking Union Medical College Hospital Beijing, China
  • Peking University First Hospital Beijing, China
  • Peking University People s Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
View all 27 locations
View Trial Details

Related conditions